Antimicrobial resistance of Salmonella isolates in a Spanish hospital

Antimicrob Agents Chemother. 1993 May;37(5):1200-2. doi: 10.1128/AAC.37.5.1200.

Abstract

We studied 961 clinical Salmonella isolates (one per patient) seen in one Spanish hospital from 1988 to 1991. The incidence of non-Salmonella typhi Salmonella infections per 100,000 admissions increased from 3.93 to 5.98. Overall rates of resistance to ampicillin, chloramphenicol, and co-trimoxazole were 32, 11, and 2%, respectively. Resistance to chloramphenicol increased from 9 to 16% during the study period, while resistance to each of the other drugs remained stable. Variations related to serogroups were observed.

MeSH terms

  • Ampicillin / pharmacology
  • Ampicillin Resistance
  • Anti-Bacterial Agents / pharmacology*
  • Chloramphenicol / pharmacology
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • Drug Resistance, Microbial
  • Humans
  • Microbial Sensitivity Tests
  • Salmonella / drug effects*
  • Salmonella Infections / microbiology*
  • Spain
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology

Substances

  • Anti-Bacterial Agents
  • Chloramphenicol
  • Ampicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination